ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Kimia Biosciences will hold a board meeting on August 10, 2026, to consider and approve its standalone unaudited financial results for the quarter ending June 30, 2026.
Kimia Biosciences scheduled a board meeting for May 29, 2026, to approve audited financial results. The trading window remains closed until 48 hours after result declaration.